← Open Payments lookup

DANIEL ROTH: Open Payments

NPI 1699814350 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$404 in 16 payments from 8 companies in 2025. Trend: 2023 $151 · 2024 $536 · 2025 $404

Food & beverage: $404
CompanyPaymentsAmount
Lilly USA, LLC4$105
Novo Nordisk Inc4$104
PFIZER INC.3$72
SANOFI PASTEUR INC.1$29
AstraZeneca Pharmaceuticals LP1$26
GlaxoSmithKline, LLC.1$26
ABBVIE INC.1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$21

Products named: MOUNJARO, ELIQUIS, JARDIANCE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Ozempic, AIRSUPRA, SHINGRIX, Wegovy.

Industry payments across CA — which companies pay providers there.